en
Scientific article
Open access
English

Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG

Published inJournal of bone oncology, vol. 7, p. 1-12
Publication date2017
Citation (ISO format)
HADJI, Peyman et al. Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG. In: Journal of bone oncology, 2017, vol. 7, p. 1–12. doi: 10.1016/j.jbo.2017.03.001
Main files (1)
Article (Published version)
Identifiers
ISSN of the journal2212-1366
434views
229downloads

Technical informations

Creation05/15/2017 12:04:00 PM
First validation05/15/2017 12:04:00 PM
Update time03/15/2023 1:42:03 AM
Status update03/15/2023 1:42:02 AM
Last indexation02/12/2024 12:44:30 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack